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ABS TRACT
Background and objectives: The human immune system is an ever-changing composition of innumer-
able cells and proteins, continually ready to respond to pathogens or insults. The cost of maintaining
this state of immunological readiness is rarely considered. In this paper we aim to discern a cost to non-
acute immune function by investigating how low levels of C-reactive protein (CRP) relate to other
energetic demands and resources in adolescent Gambian girls.
Methodology: Data from a longitudinal study of 66 adolescent girls was used to test hypotheses around
investment in immune function. Non-acute (under 2 mg/L) CRP was used as an index of immune
function. Predictor variables include linear height velocity, adiposity, leptin, and measures of energy
balance.
Results: Non-acute log CRP was positively associated with adiposity (b = 0.16, P< 0.001, R2 =0.17) and
levels of the adipokine leptin (b = 1.17, P = 0.006, R2 =0.09). CRP was also negatively associated with
increased investment in growth, as measured by height velocity (b =0.58, P< 0.001, R2 = 0.13) and
lean mass deposition b =0.42, P = 0.005, R2 = 0.08). Relationships between adiposity and growth ex-
plained some, but not all, of this association. We do not find that CRP was related to energy balance.
Conclusions and implications: These data support a hypothesis that investment in non-acute immune
function is facultative, and sensitive to energetic resources and demands. We also find support for an
adaptive association between the immune system and adipose tissue.
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BACKGROUND AND OBJECTIVES
The immune system is often considered in terms of
its responses to pathogens, such as leukocyte prolif-
eration, antibody production, or rapid increases in
acute-phase proteins. These types of immune
defenses are known to be energetically costly.
Pyrogenic and non-febrile immune responses are
associated with approximately 10% increases meta-
bolic rate [1, 2], and acute immune responses are
associated with reductions in activity, body mass
and reproductive success in a wide range of animals
[3]. However, acute responses do not represent the
full metabolic cost of immune function. Normal im-
munocompetence is an active and dynamic process,
in which large populations of cells and proteins
undergo frequent turnover, with unknown associated
energetic costs. In this paper, we use a life history
perspective to investigate how energetic resources
and demands are associated with variation in non-
acute immune function.
Life history theory offers a way to understand the
interactions between competing energetic de-
mands, such as maintenance (including immune
function), growth and reproduction [4, 5]. It is well-
known that even slight changes in energy availability
can influence investment in growth and reproduc-
tion [3, 6]. We also know that both acute and chronic
immune responses can exhibit trade-offs with other
life history demands. Acute inflammation is
associated with decreased investment in linear
growth in children [7, 8], and higher levels of inflam-
matory proteins predict reduced fecundity in women
[9, 10]. Chronic illness is also associated with
reduced growth and delayed puberty [11, 12].
Building on this body of research, we investigate
how non-acute immune function relates to energy
reserves, balance and investment in other life history
demands.
In many respects, an acute immune response is a
magnification of processes that are normally present
in the body. For example, while CRP is often con-
sidered as part of the innate acute-phase response,
it is also present in healthy individuals [13], where it
circulates through the body and maintains immune
surveillance for pathogens or other insults [14]. Upon
recognition of pathogen or damage associated mol-
ecules, CRP initiates the complement system, pro-
motes opsonization, activates leukocytes and
stimulates the release of proinflammatory cytokines
[15, 16]. As part of the innate acute response, CRP
levels rise exponentially within 24–48 h after injury
or infection. There is also variation in levels of non-
acute CRP. Some of this variation is associated with
obesity and has been linked to chronic disease [17]. It
is also possible that a portion of the variation in non-
acute CRP is related to energy availability and invest-
ment in competing life history demands.
We investigate the relationship between non-acute
CRP and energetic factors such as growth and adipos-
ity with data from adolescent girls in the Gambia.
These pubertal girls are undergoing the adolescent
transition and the accentuated energy demands of
the growth spurt. During this time, individuals are
increasing energy allocation to linear growth as well
as differentially investing in tissue important to repro-
ductive capacity, such as muscle and fat [18]. The
immune system also undergoes changes during ado-
lescence, though these are less well-understood. In
terms of innate immune function, environmental fac-
tors that are known to increase inflammation in
adults are also related to inflammation in adoles-
cents, including social stress, sleep deprivation and
obesity [19–21]. Additionally, the hormonal changes
of adolescence have immunological consequences,
with growth hormone and gonadal hormones
exerting variable, and sometimes proinflammatory,
effects on innate and adaptive immunity [22–24].
Despite the complexities of immune function in ado-
lescence, this time period offers an intriguing possi-
bility for exploring the energetic cost of non-acute
immune function. Trade-offs between immune func-
tion and other demands may be especially evident in
adolescents, as they are supporting increased growth
rates as they finish maturation.
Working from our primary hypothesis that non-
acute immune function is costly, we organize a series
of analyses that test how CRP is related to energy
reserves, energy balance and investment in growth.
We predict that, even at very low levels of adipose
tissue, girls who have more energy reserves will invest
more in innate immune function. We also predict that
being in positive energy balance, characterized by fat
gain and by higher levels of C-peptide of insulin, will
be associated with higher levels of CRP. Finally, we
predict that girls who are investing more in growth
will have lower levels of non-acute CRP. The ability of
individuals to invest in growth, immune function or
reproduction is a function of their individual energy
status, and some girls may be able to support both
increased investment in growth and high levels of
investment in innate immune function [8]. Where ap-
propriate, models will investigate how such pheno-
typic correlations may influence results, as well as
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whether individuals in different stages of the adoles-
cent transition differ in investment strategy.
METHODOLOGY
Population
Study participants were 66 post-menarcheal adoles-
cent females between 14 and 19 years at enrollment,
residents of West Kiang, a rural province of The
Gambia. This is an agricultural society with docu-
mented caloric and micronutrient constraints
related to a highly seasonal environment [25].
Annually, there is a wet season (June–October),
which coincides with the period of greatest agricul-
tural labor, lowest food intake, and is characterized
by population weight loss. There is also a dry season
(November–May), in which relatively low-burden
harvest work occurs, food intake is higher and
weight is gained. Participants in the current study
were born to mothers who were enrolled in a
1989–1994 protein, energy and micronutrient sup-
plementation trial, and all participants were born
during the wet season [26]. We contacted 81 adoles-
cent females for participation in the study, and 12
refused (a 15% refusal rate). Of the remaining 69
women, three did not have serum available for CRP
analysis and are not included in this report. At the
time of the study, participants were not pregnant,
had reported at least one menstrual cycle since par-
turition if lactating, and were not using hormonal
contraception. Six participants had previously given
birth and were breastfeeding at some point during
the study. In mixed models accounting for repeat
sampling across individuals, neither having given
birth (b = 0.57, SE = 0.44, P = 0.19, R2 =0.01) nor
currently nursing (b = 0.55, SE = 0.39, P = 0.16,
R2 =0.01) were associated with log CRP.
This study uses longitudinal data from three con-
secutive seasons, the fall 2009 wet season [July 30–
October 3], the spring harvest season of 2010 [March
1–April 1] and the beginning of the fall 2010 wet sea-
son [July 14–August 12, 2010]. The majority of data
collection in 2009 overlapped with Ramadan [August
21–September 21]. In this population, fasting
associated with Ramadan is commonly observed
after puberty, and is a daylight-hours fast lasting ap-
proximately a month. During Ramadan fasting, par-
ticipants consumed their daily calories during their
evening meal, after sunset. In this sample, the dates
associated with Ramadan were associated with
higher CRP levels (Fig. 1), and in a related study of
the same subjects, both leptin levels and C-peptide
of insulin levels were significantly higher during
Ramadan than in the non-Ramadan wet season [27].
Within Season 1, samples collected strictly during
Ramadan are not significantly different than samples
collected outside of Ramadan (multilevel regression
with individual as a random group effect and a
Ramadan indicator variable predicting log CRP,
b = 0.38, P= 0.20, R2 =0.02). However, if the
Ramadan sampling period includes the week follow-
ing Ramadan, there is a statistical difference
(b = 0.94, P= 0.02, R2 =0.04). Our data suggest that
Ramadan fasting may be associated with an increase
in circulating CRP in non-obese adolescents with nor-
mal to high energy outputs, and that this effect may
persist for several days following the end of Ramadan.
However, there is not currently a substantive reason
to include these days with our Ramadan period, and
without them, Season is a superior explanation of the
variation seen. Therefore, we include Season as a vari-
able in our final models. Previous studies of the effect
of Ramadan on CRP have variously reported that
fasting lowers CRP in normal-weight individuals
[28], that it raises CRP in normal-weight individuals
but lowers CRP in obese persons [29], and that
Ramadan fasting has no effect on CRP [30], and it is
unclear whether our results are typical of Ramadan
fasting in agricultural subsistence populations. The
effects of fasting on circulating inflammatory proteins
in normal-weight individuals, especially those living
in rural and agricultural environments, deserves fur-
ther study.
This data set includes longitudinal data across
three seasons, with repeat samples for a majority
of participants (Table 1). In total, we have 299 ob-
servations of CRP from 66 individuals. There are
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Figure 1. Ramadan and CRP in Season 1. CRP and sample
collection date. Vertical lines indicate Ramadan period (Aug.
21–Sept. 21)
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three seasons of data for 36 participants, two sea-
sons of data for 16 participants, and one season for
14 participants. Most participants have two samples
of CRP per season, although up to three participants
in each season only have one sample available.
Anthropometry and body composition
Height, weight and triceps skinfold thickness were
measured in triplicate by the same trained obser-
vers. Height was measured for barefoot participants
to the nearest millimeter with a stadiometer
calibrated daily. Weight was measured in light cloth-
ing in triplicate to the nearest 0.1 kg on a battery-
operated scale (Tanita Corporation, Japan),
calibrated daily. Skinfold measures were taken with
calipers, to the nearest 2 mm. Body composition was
measured with the Tanita BC-418MA segmental
body composition analyzer at the beginning and
end of each sampling season. We used a population
specific equation for the estimation of percent fat-
free mass, validated to have a correlation with esti-
mates from deuterium of R = 0.84 (95% CI 0.79–
0.89) [31]. A modified version of this equation, which
includes using triceps skinfold measures, was used
to convert Tanita impedance readouts in Ohms into
estimates of fat and lean mass. The Tanita measure-
ments also provide information on the change of
weight and body composition within season.
Whole and segmental body composition was
measured at intake each season by DXA (Lunar
DBX, GE Lunar Corporation, Madison WI). Limb re-
gions are defined as the limbs of interest. Android
and gynoid regions are based on definitions as in Lee
et al. and Novotony et al. [32, 33]. Android regions
are defined as the region from the top of the pelvis
(bottom of the fourth lumbar) to a position equiva-
lent of 20% of the distance between the pelvis and
the femoral neck. Lateral boundaries are the lines
that mark the arm regions. The gynoid region is a
set distance (1.5 times the height of the android re-
gion) below the upper pelvis line. The lower bound-
ary is twice the height of the android region below the
upper boundary. The lateral boundaries are the lines
that mark the leg regions.
Adipose tissue measures were tightly correlated,
and we conducted a principal components analysis
to create a global measure of adiposity. The variables
included in this metric were BMI, trunk fat, arm fat,
leg fat, gynoid fat and android fat. The eigenvalue of
Table 1. Participant characteristics
Season 1 Season 2 Season 3
N = 56 N = 52 N = 45
Age (years) 17.2 (1.5) 17.4 (1.4) 17.5 (1.3)
BMI (kg/m2) 20.7 (2.8) 20.4 (2.8) 20.6 (3.1)
Adiposity (PCA metric) 0.07 (2.34) -0.21 (2.40) 0.15 (2.34)
Height Velocity (cm/year) 0.70 (0.77) 0.79 (0.77) 0.89 (0.78)
CRP (mg/L) 0.66 (1.16) 0.33 (1.15) 0.18 (0.36)
Leptin (ng/mL) 14.74 (5.22) 13.56 (5.50) 11.25 (7.35)
C-peptide (ng/mg) 28.34 (22.82) 20.21 (15.42) 14.88 (10.34)
Time Since Menarche (years) 2.1 (1.6) 2.2 (1.3) 2.4 (1.3)
Weight (kg) 53.3 (8.0) 52.8 (7.9) 53.7 (7.9)
Height (cm) 160.44 (5.66) 160.87 (5.30) 161.33 (5.50)
 Weight in Season (kg) 0.8 (1.4) 0.2 (1.2) 0.3 (0.7)
 Lean Mass in Season (kg) 0.5 (1.1) 0.3 (1.1) 0.1 (0.9)
 Fat Mass in Season (kg) 0.3 (0.9) 0.0 (0.6) 0.4 (0.6)
Skin Folds (mm) 14.5 (4.5) 18.2 (5.1) 19.1 (5.3)
Arm Fat (kg) 1.2 (0.6) 1.1 (0.7) 1.2 (0.7
Leg Fat (kg) 6.7 (2.5) 6.4 (2.6) 6.8 (2.6)
Trunk Fat (kg) 5.7 (2.6) 5.4 (2.6) 5.8 (2.5)
Android Fat (kg) 0.7 (0.4) 0.7 (0.4) 0.7 (0.4)
Gynoid Fat (kg) 3.2 (1.1) 3.0 (1.0) 3.2 (1.0)
Participant characteristics of 66 total adolescent Gambian girls across three seasons of data collection. All values are mean (standard deviation).
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the first component was 5.39 times the size of the
second, and accounts for 92.72% of the variance. No
other eigenvalue was greater than 0.16. Accordingly,
individual scores on the first principle component
were used in subsequent analyses as measures of
global adiposity.
We calculated an average linear height velocity for
each participant by averaging the change in height
between each season, adjusting for duration of time
between measurements. Two data points were
identified as outliers and removed; one had an
associated height velocity greater than 6 cm/year,
more than twice the velocity of any other participant,
the other exerted unusually high leverage due to high
CRP and a high growth velocity. Nine individuals
were present in multiple seasons and had a height
velocity of 0 cm/year, indicating they were no longer
growing. They were included the analyses. Previous
studies of childhood and adolescent growth in the
Gambia have demonstrated that, relative to British
children, growth rates are lower at all ages, including
a lower rate of peak growth velocity (averaging 6 cm/
year in girls), and that both the age of peak height
velocity (13.8 years) age of growth cessation are
delayed [34]. Given this, and the rates of growth
observed (Fig. 2), these data suggest some of these
girls are still investing heavily in growth, while grad-
ually coming to a point of growth cessation.
Lab analyses
CRP and leptin were measured from serum derived
from approximately 100 ml of peripheral whole blood
collected by finger prick into microtainer capillary
tubes. Samples were collected between 9:00 h and
11:00 h and were not fasted. CRP and leptin assays
were run on site in the Gambia, and laboratory con-
ditions were less stable, including daily temperature
fluctuations, than in our normal lab at Harvard.
Therefore, the inter-assay CVs are somewhat high.
The assays for C-peptide of insulin were run in our
Cambridge-based lab.
CRP was measured using a high-sensitivity ELISA
protocol [35], which has a functional sensitivity of
0.00015 mg/L. Samples were run in duplicate, with
an average intra-assay coefficient of variation of
5.2%. Samples that read as below the detection limit
of 0.0001 mg/L, above 10 mg/L, or with coefficients
of variation over 20% were rerun. The average intra-
assay coefficient of variation for the low control was
2.4% and for the high control was 3.1%. The average
inter-assay coefficient of variation for the low control
was 23.7% and for the high control was 23.8%
(N = 11). We explored the significance of these high
CVs for our analysis through the inclusion of a
dummy variable for plate. Results were unaffected.
CRP values were not normally distributed, and were
logged for analysis.
C-reactive protein is a part of the acute response,
and it is necessary to exclude values indicative of
acute inflammation. Unlike the chronically elevated
CRP levels often seen in Western populations, here
no individual had consistent CRP above 3 mg/L,
though the CRP of one individual with a very high
BMI for the population (26–28 over the seasons) did
reliably fall around 1 mg/L. Given this, we use a con-
servative cut-off of 2 mg/L to exclude values indica-
tive of acute inflammation, similar to other recent
work [8, 10].
Leptin was analyzed with a commercially available
96-well plate leptin ELISA kit (BioVendor, Candler,
NC), used according to kit protocol. The intra-assay
coefficient of variation was 2.8% for the high control
and 7.8% for the low control, and the inter-assay co-
efficient of variation was 16% for the high control and
50% for the low control (N= 10). While the CV for the
low control was quite high, this represents only
2.3 ng/mL, and so is fairly minimal absolute variation.
Leptin values were not normally distributed, and were
logged for analysis.
C-peptide of insulin, a prohormone produced in a
1:1 ratio with insulin and secreted in urine, was
measured in fasted first morning void urine samples
dried on saturated filter paper by validated methods
[36]. C-peptide of insulin was measured by radio-
immunoassay according to kit protocols (Human
C-peptide RIA kit manufactured by Millipore, cata-
logue number HCP-20K). Creatinine corrections
Figure 2. Linear height velocity by age. Height velocity de-
creases with increasing age. One outlier with a height velocity
over 6 cm/year was excluded for this image
Energetics and the immune system Shattuck-Heidorn et al. | 31
Downloaded from https://academic.oup.com/emph/article-abstract/2017/1/27/2730515
by London School of Hygiene & Tropical Medicine user
on 15 December 2017
were applied to adjust for urinary concentration
[37]. The intra-assay coefficient of variation for
the high control was 13.4% and for the low con-
trols 13.8%. Inter-assay coefficients of variation
were 10.1% for high and 15.7% for low controls
(N = 13 assays). The sensitivity of the assay was
0.01 ng/ml. Analyses used C-peptide of insulin
levels indexed to the individual, meaning
normalized in reference to the average level for
each individual.
Statistics
Statistical analysis was performed in Stata 13. All
models predict natural-log transformed serum
CRP. As our longitudinal dataset contains repeat
measures from the same individuals, the re-
siduals are no longer independent. Models are
linear mixed models, with individual as a random
effect.
RESULTS
Associations between CRP and energy
status
Over the study as a whole, participants were an
average of 17.35 years old (sd 1.41), and 2.23 years
post-menarcheal (sd 1.44). As continuous vari-
ables, in single predictor models, neither chrono-
logical age (b =0.03, SE = 0.08, P= 0.75,
R2 =0.01) nor time since menarche (b = 0.04,
SE = 0.08, P= 0.59, R2=0.03) were associated with
CRP. While it is not significant, we include age as a
covariate in our full models below.
The relationship between adiposity and CRP
was present even in very lean individuals. In a
single predictor, mixed model with individual
random-effects, our global measure of adiposity
positively predicted log CRP (b = 0.16, SE = 0.04,
P< 0.001, R2 = 0.17). Including individuals with
CRP over 2 mg/L did not affect the model
(b = 0.19, SE = 0.04, P< 0.001, R2 =0.17).
Including age and season as covariates did not
influence the significance of adiposity as a pre-
dictor of CRP (Model 1, Table 2). These results
suggest a relatively continuous relationship be-
tween adiposity and CRP, even at very low levels
of both (Fig. 3).
The adipokine leptin also positively predicted
CRP levels. Leptin values were logged for ana-
lysis, thus the coefficient is interpretable as
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indicating the percent change in CRP associated
with a percent change in leptin. In a single predictor
model, a 10% change in leptin levels was associated
with an approximately 12% change in non-acute CRP
(b = 1.17, SE = 0.42, P = 0.006, R2 =0.09, Model 2,
Table 2). This association was strengthened if CRP
values above 2 mg/L were included in the model
(b = 1.69, SE = 0.48, P< 0.001, R2 =0.10). Our adi-
posity metric had a strong positive correlation with
leptin, Pearson’s R = 0.69, P< 0.001. In models
including adiposity, age and season as covariates,
the association between leptin and CRP lost signifi-
cance (Model 3, Table 2).
Associations between CRP and energy balance
Contrary to our prediction that positive energy bal-
ance would be associated with higher investment in
non-acute immune function, CRP did not differ sig-
nificantly between individuals who were gaining fat
within a season and those who were losing fat
(b = 0.20, SE = 0.17, P = 0.24, R2 =0.01). This finding
was not affected by including individuals with CRP
above 2 mg/L in the model, or by including age, sea-
son and adiposity as covariates. Because prior work
from this population found that older and younger
individuals differ in how they prioritize tissue gain
and loss, we considered whether pubertal transition
stage may be influencing the relationship between
energy balance and allocation to maintenance, and
investigated models that included interaction terms
between fat gain and age, as well as fat gain and a
dichotomous growth velocity indicator (above or
below 1 cm/year). We did not find any significant
interactions between fat gain and these covariates
of pubertal transition.
In a single predictor model, there was a positive
relationship between CRP and C-peptide of insulin, a
marker of insulin status and energy balance, though
it did not explain much of the variation present
(b = 0.44, SE = 0.15, P = 0.003, R2 =0.02). This rela-
tionship may be due to higher C-peptide of insulin
and higher CRP in season 1, as when we included
season as a covariate the relationship lost signifi-
cance (Model 4, Table 2).
Associations between CRP and investment in
growth
Adolescent girls who were investing more in growth
had lower CRP values than individuals who were in-
vesting less in growth. The single predictor model in-
dicates that height velocity was negatively associated
with log CRP (b =0.58, SE = 0.14, P< 0.001,
R2 =0.13, Fig. 4). Including individuals with CRP re-
sults over 2 mg/L increased the strength of this asso-
ciation. In models including adiposity, age and
season, height velocity continued to negatively predict
CRP (Model 4, Table 2). These results were not af-
fected by including individuals with CRP over 2 mg/L
in the model. The association between current invest-
ment in linear growth and CRP did not extend to
height. Neither height (b =0.01, SE = 0.02, P= 0.75,
R2 =0.0001), nor a height-for-age z-score (b =0.03
SE = 0.16, P= 0.87, R2 =0.0003) were associated with
CRP.
As an alternative metric of investment in growth,
while in a single predictor model individuals who
gained lean mass within a season had significantly
lower CRP than those who were losing lean mass
(b =0.42, SE = 0.15, P = 0.005, R2 =0.08), this
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Figure 3. Log CRP by adiposity PCA score. Log CRP versus
score on first component of adiposity PCA. Model is mixed-
effects, with fixed-effects coefficient for adiposity component
specifying the regression line (b = 0.16, P< 0.001, R2 = 0.17)
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Figure 4. Log CRP by height velocity. Log CRP versus height
velocity (cm/year). Model is mixed-effects, with fixed-effects
coefficient for height velocity specifying the regression line
(b =-0.58, P< 0.001, R2 =0.13)
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association lost significance (b =0.25, SE = 0.15,
P = 0.09) in models including adiposity, season,
and age. Individuals who were gaining lean mass
were also more likely to have higher growth velocity,
though the correlation is relatively weak (Pearson’s
R = 0.22, P = 0.001).
Adiposity appears to mediate the investment be-
tween immune function and growth (Fig. 5).
Independent-group t-tests were conducted to com-
pare mean log CRP levels between groups of girls
based on investment in growth and adipose re-
serves, as defined by median splits for height velocity
and global adiposity. Considering first girls who were
investing less in growth, individuals with lower adi-
posity had lower CRP (M =2.28, SD = 1.09) than
individuals with higher adiposity (M =1.87,
SD = 1.09, t = 2.02, P = 0.05), though the difference
becomes non-significant when including CRP values
over 2 mg/L. Only eight girls were both investing
heavily in growth and had high adiposity, however
their CRP levels (M =1.63, SD = 0.97) did not differ
significantly from girls with similar levels of adipos-
ity who were not investing in growth (M =1.87,
SD = 1.09, t =1.10,P = 0.28). Girls who were invest-
ing in growth and had low adiposity had the lowest
CRP levels of any group (M =2.74, SD = 1.10), sig-
nificantly lower than girls with low adiposity who
were not growing (t = 2.19, P = 0.03) and girls who
were growing but had higher adipose reserves
(t =5.09, P< 0.001).
In a full model including all predictors (height vel-
ocity, C-peptide of insulin, log leptin, adiposity, sea-
son and age), height velocity retains independent
power for predicting log CRP (Model 5, Table 2).
CONCLUSION AND IMPLICATIONS
As a lean population going through the pubertal tran-
sition under conditions of general energetic con-
straint, Gambian adolescent girls manifest the sorts
of trade-offs in energetic investment that are predicted
by life history theory. That theory stipulates that at
each point in an organism’s life, energy is allocated
between non-overlapping physiological categories in
ways that optimize fitness [5, 38]. The adolescent tran-
sition is a particularly useful time to consider energetic
dynamics, as during puberty investment in linear
growth is first increased (the adolescent growth spurt)
and then terminated. Meanwhile, investment in repro-
duction, manifested in females as the development of
primary and secondary sexual characteristics and an
increased metabolic priority given to energy storage as
fat, increases as investment in growth subsides [18].
For instance, prior work from our group demonstrated
that, in this participant sample, younger individuals
prioritize lean mass, even at the expense of fat, while
older individuals prioritize the fat deposits critical for
reproductive success [39]. While the trade-off between
growth and reproduction during the pubertal transi-
tion is readily observed and rationalized, attention is
rarely directed at investment in maintenance over the
same period. Our primary hypothesis here was that
maintenance of the immune system might represent a
substantial, flexible component of overall energetic
costs, one that could be expected to covary with other
energetic demands and resources during puberty.
In support of this hypothesis, we find evidence
that increased allocation of energetic resources to
growth may come at a cost to non-acute immune
function, particularly in girls with low adipose tissue
reserves. In this sample, girls who were growing
faster and girls who were depositing lean mass
had, on average, lower non-acute CRP. We interpret
this as evidence that, in this energy-limited environ-
ment, these girls were subsidizing the increased
costs of growth in early adolescence through
decreasing investment in non-acute immune
function.
We also find that, regardless of pubertal transition
stage, individuals who had more available energy
stores, as measured by a global adiposity metric
and the hormone leptin, invested more in non-acute
immune function. That adiposity was positively
associated with CRP may seem unsurprising given
the well-known relationships between obesity and
inflammation [17]. However the inflammation
induced by obesity is understood to result from
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Figure 5. Relationships between log CRP, investment in
growth and adiposity. Adiposity mediates the relationship be-
tween log CRP and growth. Girls who are investing heavily in
growth and have low adipose reserves have significantly lower
log CRP levels than the other groups in the figure
34 | Shattuck-Heidorn et al. Evolution, Medicine, and Public Health
Downloaded from https://academic.oup.com/emph/article-abstract/2017/1/27/2730515
by London School of Hygiene & Tropical Medicine user
on 15 December 2017
pathological processes such as the increased re-
cruitment of macrophages into adipose tissue in re-
sponse to stress signals from enlarged adipocytes
[40]. Here we find that CRP, in a range well below the
chronic levels understood to result from obesity, is
positively associated with adiposity, even in very
lean subjects. We interpret this as evidence of a
non-pathological relationship between adipose tis-
sue and innate immunocompetence.
An adaptive relationship between adipose tissue
and innate immunocompetence is congruent with
several other lines of evidence. The fat body of in-
sects regulates energy metabolism and storage and
is also the site of immune and antibacterial re-
sponses [41, 42]. And it is well-known that a min-
imum level of body fat and the hormone leptin is
necessary to maintain T-mediated immunity [43],
and that leptin can regulate inflammatory immune
processes, including stimulating Il-6 production in
macrophages [44, 45]. This is congruent with our
initial evidence that leptin positively predicts CRP,
but here the relationship between leptin and CRP
appears to be entirely mediated by adiposity. We
also note the unexpected finding that in the final full
model leptin negatively predicts CRP. In-vitro, leptin
is reliable at stimulating inflammatory immune
function (reviewed in [45]), but in human popula-
tions the relationship to immunity is often more
complex. For instance, previous research in this
population finds no relationship between leptin
levels and acquired immune function in moderately
undernourished children [46]. While the specifics of
how adipose tissue influences CRP are complex, our
results support a strong relationship between adi-
posity and innate immune function. An acute im-
mune response imposes a substantial energetic
cost in a relatively short time frame, and adipose
reserves are critical for subsidizing immune re-
sponses in energy-limited environments. The innate
immune system has been hypothesized to be more
energetically costly than acquired immunity [47], and
may be especially sensitive to energetic indicators.
The relationships between adipose tissue, leptin and
immune function suggest that organisms increase
innate immune vigilance when adipose tissue re-
serves are sufficient to fund acute immune
responses.
This framework, of considering the cost of an
acute response as underlying the coupling of non-
acute immune function to energetic reserves, also
aids in interpreting why we do not find that energy
balance, as measured by C-peptide of insulin or fat
gain, was related to non-acute CRP. Positive energy
balance does not necessarily correlate with large en-
ergy reserves. An organism could be gaining fat, or
have a current caloric excess, but still have very low
absolute levels of adipose tissue. While organisms
may use markers of energetic balance to judge
whether to embark upon long term energetic pro-
jects, such as female reproduction [6], an acute im-
mune response will demand a large amount of
energy in a short period of time [3]. Given this, it
may be more reliable for organisms to use signals
of energetic reserves to calibrate immune function,
rather than energy balance.
Our findings suggest that there is a non-trivial
metabolic cost either inherent in CRP production,
or closely associated with levels of CRP. CRP has a
half-life of 18 h [48], indicating that this population of
proteins is undergoing frequent turnover, requiring
some relatively constant commitment of energetic
resources, though the metabolic cost of this is un-
known. Our data also imply that there are meaning-
ful differences in low levels of CRP. Interestingly,
administration of human CRP to mice protects
against pneumococcal infections, but not if CRP is
administered after exposure to the bacteria, suggest-
ing an early prophylactic function may be associated
with CRP levels [49]. If CRP has a similar function in
humans, our data would suggest that adolescence,
in particular the period of the growth spurt, may be
accompanied by increased risk of illness. While
some pathogen infections are more frequent in ado-
lescence [50], it is difficult to parse behavioral from
physiological influences without direct measure-
ment of the growth spurt. Alternatively, changes in
levels of CRP may signify broader shifts in immuno-
competence, perhaps particularly in innate im-
munocompetence, and not be specific to the
action of CRP in particular. Outside of the context
of chronic disease and pathology, the functional sig-
nificance of variation in low-level CRP deserves
study, as does the relationship between other as-
pects of immunocompetence, such as lymphocyte
populations, and energetic demands.
In this work, we find that increased investment
in growth is associated with reduced investment in
non-acute immune function. Could investment in
other energetic demands, such as reproduction or
physical activity, also evidence trade-offs with non-
acute immune function? Intriguingly, two recent
studies support a hypothesis that there are some
trade-offs between female reproductive function
and higher levels of CRP. Though they do not
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specifically investigate non-acute CRP, these studies
found that higher levels of CRP are associated with
anovulation and lower levels of progesterone and
estrogen [9, 10]. Concerning physical activity, vigor-
ous exercise is known to suppress cell-mediated im-
munity and increase the risk of illness, while more
moderate exercise generally has an anti-inflamma-
tory effect [51]. How other types of physical activity,
such as that associated with agricultural lifestyles,
relates to immune function is an important locus for
future research.
The dominant public health discourse concerning
CRP is one of pathology and “chronic inflamma-
tion”, yet for at least a decade human biologists
working in non-Western populations have found
lower CRP than expected, and more complicated re-
lationships between CRP and metabolic disease [52,
53]. We note that our CRP values are quite low in
comparison to adult values from North America
and Europe, though they are similar to those seen
in other non-obese adolescent populations [54–58].
In our increasingly transnational world, understand-
ing the significance of immunological biomarkers
such as CRP, in both clinical and non-clinical
settings, will require integrating knowledge of how
different ecological contexts influence the manifest-
ation of non-acute immune function.
While working with a subsistence agricultural
population of pubertal girls has important benefits
for understanding diversity in immune strategies,
we should also keep in mind several limitations of
this study. These include a relatively modest sample
size and unequal representations of individuals
across the seasons. We also cannot infer causality
from these data. Our use of longitudinal data and a
relatively stringent cut-off for acute CRP attempts to
avoid biasing our data with individuals who are ac-
tively experiencing immune responses. However, it
is possible that we are including some girls who have
slightly elevated CRP and low growth because they
have recently been sick. More broadly, it is unclear
whether these relatively slight differences in CRP
would be measurable in populations with higher
rates of inflammation associated with obesity, or if
these patterns would hold in populations living in
environments with easy access to quick calories.
In summary, we contribute to a body of literature
that emphasizes the importance of considering im-
mune function as a metabolically expensive life his-
tory demand that may evidence sensitivity to
energetic resources, and trade-offs with other de-
mands. The constant production of cells and
proteins required for immune vigilance is an import-
ant part of the energetic budget of organisms. The
results of this paper support an understanding of
investment in normal immunocompetence as a
non-trivial energetic expense, one which may be
drawn upon if needed to support other somatic
strategies, and that may be tied to energetic reserves
within the organism. We look forward to future re-
search that aims to better quantify the cost of non-
acute immune function.
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